Hannah Went is a biology graduate from the University of Kentucky with a passion for longevity & disruptive technologies. She has a background in cell signaling research & served as Director of Research & Content for the International Peptide Society. In 2020, she founded TruDiagnostic, a company specializing in methylation-based diagnostics for life extension & preventive healthcare.
TruDiagnostic conducts extensive research, with over 30 clinical trials & one of the world’s largest private epigenetic health databases, testing over 35,000 patients. Hannah also created Everything Epigenetics to share insights on how DNA regulation impacts health.
